Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

BAKER CAPITAL STRATEGIES

Get the free weekly BCS email.

Selected company filings and market updates, delivered by email. Your first report will follow soon.

  • Your weekly BCS reportMarket updates and links to filings you can explore.
  • THEMA at launchWe’ll send directions for setting up your filing alerts when THEMA officially opens.

One signup for the weekly email and your free THEMA Basic account at launch.

Already registered or a CSW member?Log in to THEMA →

At least 8 characters. This also creates your free THEMA account for launch.

You’re signing up for the weekly BCS email and THEMA launch/setup updates. Unsubscribe using the link in any email. Privacy policy · Terms

BCS

Changes in Beneficial Ownership · 4

Ingevity Corporation

NGVTNYSEEQUITYCurrent

Changes in Beneficial Ownership

Filed Aug 14, 2026Accepted Aug 14, 2026, 5:06 PM EDTFiling CIK 1653477Accession 0001436880-26-000006
Share

Structured filing — 4

wk-form4_1786741576.xml

Open full document ↗

Filing details

Report period
2026-08-12
Issuer
Ingevity Corp
Issuer CIK
0001653477
Trading symbol
NGVT
Rule 10b5-1 indication
Checked

Reporting owner 1

Name
Li David H
Reporting owner CIK
0001436880
Relationship
Director · Officer
Officer title
President & CEO
Address
C/O INGEVITY CORPORATION, 4920 O'HEAR AVE, SUITE 400, NORTH CHARLESTON, SC, 29405

Non-derivative transactions

Non-derivative transactions · 2 reported rows
SecurityTransaction dateCodeAmountA / DPrice (USD)Owned afterOwnership
Common Stock2026-08-12S · Form 45,000D76.62[F1]135,636D
Common Stock2026-08-13S · Form 45,000D75.73[F2]130,636D
Table key
S · Form 4
Sale on the market or privately
D
Direct

Footnotes

F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $76.14 to $78.22, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.↩ 1
F2
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.18 to $76.26, inclusive. The reporting person undertakes to provide to the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.↩ 1

Signature 1

Signed
David H. Li By: Mavis G. Huger as Attorney-in-Fact
Date
2026-08-14

Company context

Current securities

Recent company filings

  1. 4 filingOct 2, 2026
  2. 10-Q filingJul 30, 2026
  3. Results of Operations and Financial ConditionJul 29, 2026
  4. 4 filingJul 2, 2026
  5. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory ArrangementsJun 24, 2026

Privacy choices

BCS measures page use with Google Analytics using regional consent settings. You can change your preference here. Charts and market data remain available.

Essential functions — always available. Security, navigation, registration and remembering these choices.

Audience analytics

Analytics cookies are off by default for visitors Google identifies in the EEA, UK or Switzerland until allowed. Limited measurement without analytics cookies may still occur under those regional defaults.

TradingView charts, quotes and the economic calendar load automatically as page content. TradingView receives network and browser information and may collect its own usage analytics. This choice controls BCS’s Google Analytics only.

Google advertising is not enabled. Direct sponsor links do not load advertising trackers on BCS.

Turning analytics off stops future Google Analytics activity here. It does not erase information already received by the provider. Read the privacy policy.